Microcirculation and left-ventricular hypertrophy

Journal of Hypertension

Volumn 30, Issue 3, 2012, Pages 477-481

  Angeli, Fabio ^a   Reboldi, Gianpaolo ^b   Verdecchia, Paolo ^c  

^a Hospital Media Valle Del Tevere   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Assisi Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AORTA STENOSIS; ARTERIAL PRESSURE; CAPILLARY DENSITY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; MICROCIRCULATION; NONHUMAN; NOTE; PRIORITY JOURNAL; SWINE; VASCULAR RESISTANCE;

EID: 84856891639     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834fa9d9     Document Type: Note

References (40)

1. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102:470-479. (Pubitemid 30490688)
2. Verdecchia P, Angeli F, Achilli P, Castellani C, Broccatelli A, Gattobigio R, et al. Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events? Curr Opin Cardiol 2007; 22:329-334. (Pubitemid 46897285)
3. Verdecchia P, Angeli F, Pittavini L, Gattobigio R, Benemio G, Porcellati C. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients. Ital Heart J 2004; 5:505-510.
4. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75:4-11. (Pubitemid 13009927)
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566. (Pubitemid 20176696)
6. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78:197-202. (Pubitemid 26244369)
7. Verdecchia P, Angeli F, Reboldi G, Carluccio E, Benemio G, Gattobigio R, et al. Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am J Hypertens 2003; 16:646-652. (Pubitemid 36900587)
8. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
9. Diez J, Gonzalez A, Lopez B, Querejeta R. Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease. Nat Clin Pract Cardiovasc Med 2005; 2:209-216. (Pubitemid 40812484)
10. Koren MJ, Devereux RB. Mechanism, effects, and reversal of left ventricular hypertrophy in hypertension. Curr Opin Nephrol Hypertens 1993; 2:87-95.
11. Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998; 16:1031-1041. (Pubitemid 28367959)
12. Ciulla M, Paliotti R, Hess DB, Tjahja E, Campbell SE, Magrini F, et al. Echocardiographic patterns of myocardial fibrosis in hypertensive patients: endomyocardial biopsy versus ultrasonic tissue characterization. J Am Soc Echocardiogr 1997; 10:657-664. (Pubitemid 127799951)
13. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26:195-202.
14. Marcus ML, Doty DB, Hiratzka LF, Wright CB, Eastham CL. Decreased coronary reserve: a mechanism for angina pectoris in patients with aortic stenosis and normal coronary arteries. N Engl J Med 1982; 307:1362-1366. (Pubitemid 13233012)
15. Opherk D, Mall G, Zebe H, Schwarz F, Weihe E, Manthey J, et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984; 69:1-7. (Pubitemid 14215854)
16. Scheler S, Motz W, Strauer BE. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am J Cardiol 1994; 73:478-482. (Pubitemid 24096210)
17. Nitenberg A, Antony I. Epicardial coronary arteries are not adequately sized in hypertensive patients. J Am Coll Cardiol 1996; 27:115-123. (Pubitemid 26018925)
18. Mulvany MJ. Vascular growth in hypertension. J Cardiovasc Pharmacol 1992; 20 (Suppl 1):S7-11.
19. Heron MI, Kuo C, Rakusan K. Arteriolar growth in the postnatal rat heart. Microvasc Res 1999; 58:183-186. (Pubitemid 29419944)
20. Rakusan K, Cicutti N, Sladek T. Ischemic heart: microcirculatory aspects. Adv Exp Med Biol 1996; 388:457-461. (Pubitemid 26317559)
21. Huo Y, Kassab GS. Compensatory remodeling of coronary microvasculature maintains shear stress in porcine left-ventricular hypertrophy. J Hypertens 2012; 30:608-616.
22. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86:38-46.
23. Flanagan MF, Fujii AM, Colan SD, Flanagan RG, Lock JE. Myocardial angiogenesis and coronary perfusion in left ventricular pressureoverload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration. Circ Res 1991; 68:1458-1470.
24. Flanagan MF, Aoyagi T, Currier JJ, Colan SD, Fujii AM. Effect of young age on coronary adaptations to left ventricular pressure overload hypertrophy in sheep. J Am Coll Cardiol 1994; 24:1786-1796. (Pubitemid 24369207)
25. Tomanek RJ. Age as a modulator of coronary capillary angiogenesis. Circulation 1992; 86:320-321.
26. Tomanek RJ, Schalk KA, Marcus ML, Harrison DG. Coronary angiogenesis during long-term hypertension and left ventricular hypertrophy in dogs. Circ Res 1989; 65:352-359. (Pubitemid 19194621)
27. Breisch EA, White FC, Bloor CM. Myocardial characteristics of pressure overload hypertrophy. A structural and functional study. Lab Invest 1984; 51:333-342. (Pubitemid 14002345)
28. Tomanek RJ, Aydelotte MR, Butters CA. Late-onset renal hypertension in old rats alters myocardial microvessels. Am J Physiol 1990; 259:H1681-1687.
29. Kobayashi N, Kobayashi K, Hara K, Higashi T, Yanaka H, Yagi S, et al. Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats. Am J Hypertens 1999; 12:483-491. (Pubitemid 29239684)
30. Motz W, Strauer BE. Improvement of coronary flow reserve after longterm therapy with enalapril. Hypertension 1996; 27:1031-1038. (Pubitemid 26140657)
31. Nunez E, Hosoya K, Susic D, Frohlich ED. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR. Hypertension 1997; 29:519-524. (Pubitemid 27074094)
32. Rakusan K, Cicutti N, Kazda S, Turek Z. Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats. Hypertension 1994; 24:205-211. (Pubitemid 24239429)
33. Chillon JM, Baumbach GL. Effects of an angiotensin-converting enzyme inhibitor and a beta-blocker on cerebral arterioles in rats. Hypertension 1999; 33:856-861. (Pubitemid 29140446)
34. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
35. Dahlof B, Hansson L. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide. J Intern Med 1993; 234:271-279. (Pubitemid 23263414)
36. Weber KT, Janicki JS, Pick R, Capasso J, Anversa P. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol 1990; 65:1G-7G. (Pubitemid 20147248)
37. Gonzalez A, Lopez B, Querejeta R, Diez J. Regulation of myocardial fibrillar collagen by angiotensin II. A role in hypertensive heart disease? J Mol Cell Cardiol 2002; 34:1585-1593. (Pubitemid 35454474)
38. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115:41-46. (Pubitemid 36831120)
39. Struijker-Boudier HA, Rosei AE, Bruneval P, Camici PG, Christ F, Henrion D, et al. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J 2007; 28:2834-2840. (Pubitemid 350233027)
40. De Boeck BW, Cramer MJ, Oh JK, van der Aa RP, Jaarsma W. Spectral pulsed tissue Doppler imaging in diastole: a tool to increase our insight in and assessment of diastolic relaxation of the left ventricle. Am Heart J 2003; 146:411-419. (Pubitemid 37083075)